|
Jul 30
|
Will PROCEPT BioRobotics Corporation (PRCT) Report Negative Earnings Next Week? What You Should Know
|
|
Jul 29
|
Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference
|
|
Jul 29
|
AxoGen (AXGN) Earnings Expected to Grow: Should You Buy?
|
|
Jul 28
|
When Will Axogen, Inc. (NASDAQ:AXGN) Breakeven?
|
|
Jul 22
|
Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025
|
|
May 28
|
Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference
|
|
Feb 18
|
We Might See A Profit From Axogen, Inc. (NASDAQ:AXGN) Soon
|
|
Oct 24
|
Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024
|
|
Jul 23
|
Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
|
|
Jun 25
|
AxoGen's (AXGN) New Launch to Aid Peripheral Nerve Protection
|
|
Jun 24
|
The past three years for AxoGen (NASDAQ:AXGN) investors has not been profitable
|
|
Jun 24
|
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
|
|
May 16
|
Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
|
|
May 14
|
Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference
|
|
May 6
|
AxoGen, Inc. (NASDAQ:AXGN) Q1 2024 Earnings Call Transcript
|
|
May 3
|
AxoGen First Quarter 2024 Earnings: Misses Expectations
|
|
May 3
|
Axogen Inc (AXGN) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amidst Challenges
|
|
May 2
|
AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates
|
|
May 2
|
Axogen, Inc Reports First Quarter 2024 Financial Results
|
|
May 1
|
AxoGen, Inc. (NASDAQ:AXGN) is largely controlled by institutional shareholders who own 58% of the company
|